Lewis, Sara http://orcid.org/0000-0002-4713-6453
Cedillo, Mario A.
Lee, Karen M.
Bane, Octavia
Hectors, Stefanie
Ma, Weiping
Wang, Pei
Stocker, Daniel
Morris, Darrell V.
Pinato, David
Sung, Max
Marron, Thomas
Schwartz, Myron
Taouli, Bachir
Article History
Received: 23 August 2021
Revised: 9 December 2021
Accepted: 10 December 2021
First Online: 29 December 2021
Declarations
:
: Stefanie Hectors: Employment at Regeneron Pharmaceuticals. David Pinato: Lecture fees (ViiV Healthcare, EISAI, BMS, Roche, Bayer Healthcare), travel expenses (BMS, MSD and Bayer Healthcare), consulting fees (Mina Therapeutics, EISAI, Roche, Astra Zeneca, DaVolterra) research funding to institution (MSD, BMS, Biognosys). Thomas Marron: Advisory boards and/or DSMBs (Boehringer Ingelheim, BMS, AstraZeneca, Genentech, Celldex, and Regeneron), research grant support (BMS, Regeneron and Boehringer Ingelheim). Bachir Taouli: Grant/research support (Bayer, Takeda, Regeneron, Siemens, Echosens). The remaining authors (SL, MAC, KML, OB, WM, PW, DS, DVM, MS, and MS) have no relevant disclosures.
: Because this work involves the use of human subjects, we ensure that all procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. The study was approved by the Institutions Review Board at the ISMMS.
: Waiver of informed consent was obtained.
: N/A.